Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Joonho Jeong, Jung Woo Shin, Seok Won Jung, Eun Ji Park, Neung Hwa Park

Clin Mol Hepatol. 2022;28(2):254-264. Published online December 28, 2021

DOI: https://doi.org/10.3350/cmh.2021.0314

View: 4898 Download: 277 Web of Science: 17 Crossref: 20

Hung-Yao Lin, Tai-Chung Tseng

Clin Mol Hepatol. 2022;28(2):181-182. Published online February 21, 2022

DOI: https://doi.org/10.3350/cmh.2022.0028

View: 3838 Download: 116 Web of Science: 3 Crossref: 3

Lilian Yan Liang, Grace Lai-Hung Wong

Clin Mol Hepatol. 2019;25(2):172-180. Published online February 12, 2019

DOI: https://doi.org/10.3350/cmh.2018.0106

View: 9305 Download: 394 Web of Science: 43 Crossref: 45

1 |

Viewed By 5256	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5199	MAFLD: How is it different from NAFLD?
Viewed By 5108	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3830	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3764	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search